Structure (Tizanadine Tabs Dr Reddy 1)
Tizanidine
Product Images NDC 33261-103
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 33261-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig1 (Tizanadine Tabs Dr Reddy 2)
This text appears to be a chart or graph displaying the "Improvement In Ashworth Score" over time after taking either 16 mg tizanidine or a placebo. The x-axis appears to show "Hours Post-Dose" and the y-axis may show the degree of improvement in Ashworth Score. The chart may be comparing the effectiveness of 16 mg tizanidine versus the placebo.*
Fig2 (Tizanadine Tabs Dr Reddy 3)
The text describes results of a study that was conducted to evaluate the effect of zanidine on the Ashworth Score. The study was conducted over a period of 7 weeks, with the dose of zanidine being 28.6 mg. The improvement in Ashworth Score was measured at Week 3 and Week 7, which was the end of the maintenance endpoint. The study used the Last Observation Carried Forward method.*
Image Label (Tizanadine Tabs Dr Reddy 4)
This is a label for a medication called Tizanidine HCL produced by AIDAREX Pharmaceuticals LLC as a generic version of the drug Zanaflex. It includes the NDG number 39261.0103-30 and the code S07ass A.*
Image Label (Tizanadine Tabs Dr Reddy 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
